We engage in the research, development, and commercialization of cell-based therapeutics for use in regenerative medicine.
Cesca is a leader in the development and commercialization of automated blood and bone marrow processing systems that enable the separation, processing and preservation of cell and tissue therapy products. The Company’s platform systems offer solutions for the delivery of autologous (obtained from the same individual) cell therapies that address significant unmet medical needs. Cesca’s strategy is to partner with other pioneers in the stem cell arena to accelerate clinical evaluations, expedite regulatory approvals and penetrate the market.
ThermoGenesis, our device division, is a leading developer of automated technologies for clinical biobanking, point-of-care cell-based therapeutics and cellular processing for immuno-oncology and other clinical applications.
Cesca Clinical, our therapeutics division, leverages our proprietary cellular processing technology platform to develop safe and efficacious point-of-care therapies targeting a broad range of indications with unmet medical needs, including osteoarthritis and critical limb ischemia. Our goal is to establish partnerships to further advance these promising programs. Learn More
Boyalife is committed to innovative drug discovery, Precision Medicine technology, health management and disease model research. We are building an internationally influential life and health industry chain.